Inovio Pharmaceuticals Current Deferred Revenue (Quarterly) Insights

Inovio Pharmaceuticals, Inc. (INO)

1.765 +0.04 (+2.02%) USD | NASDAQ | Dec 30, 16:00

1.765 0.00 (0.00%) After-Hours: 16:24

View Current Deferred Revenue (Quarterly) for INO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Agenus, Inc.	Upgrade
Perspective Therapeutics, Inc.	Upgrade
Arcturus Therapeutics Holdings, Inc.	Upgrade
Capricor Therapeutics, Inc.	Upgrade
Myomo, Inc.	Upgrade